Medicinal chemistry of β-lactam antibiotics | ||
| dc.conicet.nroedicion | 8 | es |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Química Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Química Rosario | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Biología Molecular y Celular de Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Biología Molecular y Celular de Rosario | |
| dc.conicet.organizacion | University of Notre Dame-Indiana | |
| dc.conicet.organizacion | University of Notre Dame-Indiana | |
| dc.conicet.paginas | 190 | es |
| dc.contributor.author | Testero, Sebastian Andres | |
| dc.contributor.author | Llarrull, Leticia Irene | |
| dc.contributor.author | Fisher, Jed F. | |
| dc.contributor.author | Mobashery, Shahriar | |
| dc.contributor.other | Abraham, Donald J. | |
| dc.contributor.other | Myers, Michael | |
| dc.date.issued | 2021 | es |
| dc.description.abstract | The β-lactam class of antibacterials is a cornerstone of human health. For nearly eight decades, their unparalleled clinical efficacy and clinical safety have made the β-lactam class preeminent in the treatment of bacterial infection. The relatively brief period in human history during which the β-lactams have exerted this benefit is a period characterized by continuous medicinal chemistry innovation, seen visibly in the progression from the penicillins to the complex ensemble of β-lactams (now including also cephalosporins, monobactams, and carbapenems) used in the clinic. The key force behind this innovation is the progressive evolution by bacteria of resistance mechanisms. Today, highly resistant bacteria challenge the way medicinal chemists contemplate the creative alteration of β-lactam structures, the way the pharmaceutical industry develops β-lactams (and other antibacterial) structures, and the way the medical community uses antibacterials. This article gives a concise summary of the history of the β-lactams. Its emphasis is recent structural innovation with respect to the β-lactams, and with respect to structurally related classes that act to preserve the clinical activity of the β-lactams through inhibition of bacterial β-lactam-hydrolyzing, and thus β-lactam-deactivating, enzymes. We integrate these chemistry advances with new biological discoveries with respect to the bactericidal mechanism of the β-lactams and with respect to bacterial resistance mechanisms. The combination of these perspectives is a foundational perspective to guide the medicinal chemistry future of the β-lactams. | es |
| dc.description.fil | Fil: Testero, Sebastian Andres. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Química Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Química Rosario; Argentina | |
| dc.description.fil | Fil: Llarrull, Leticia Irene. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Biología Molecular y Celular de Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Biología Molecular y Celular de Rosario; Argentina | |
| dc.description.fil | Fil: Fisher, Jed F.. University of Notre Dame-Indiana; Estados Unidos | |
| dc.description.fil | Fil: Mobashery, Shahriar. University of Notre Dame-Indiana; Estados Unidos | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Testero, Sebastian Andres; Llarrull, Leticia Irene; Fisher, Jed F.; Mobashery, Shahriar; Medicinal chemistry of β-lactam antibiotics; Wiley; 2021; 1-190 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.isbn | 978-1-119-53030-5 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/174228 | |
| dc.journal.ciudad | Washington D.C | es |
| dc.journal.pagination | 1-190 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.language.iso | eng | es |
| dc.publisher | Wiley | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1002/0471266949.bmc226.pub2 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1002/0471266949.bmc226.pub2 | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.source.titulo | Burger's medicinal chemistry, drug discovery and development | es |
| dc.subject | B-LACTAM ANTIBIOTICS | es |
| dc.subject | RESISTANCE | es |
| dc.subject | DRUG DISCOVERY | es |
| dc.subject | ANTIBACTERIALS | es |
| dc.subject | INHIBITORS | es |
| dc.subject.classification | Química Orgánica | es |
| dc.subject.classification | Ciencias Químicas | es |
| dc.subject.classification | CIENCIAS NATURALES Y EXACTAS | es |
| dc.subject.classification | Bioquímica y Biología Molecular | es |
| dc.subject.classification | Ciencias Biológicas | es |
| dc.subject.classification | CIENCIAS NATURALES Y EXACTAS | es |
| dc.title | Medicinal chemistry of β-lactam antibiotics | es |
| dc.type | info:eu-repo/semantics/publishedVersion | |
| dc.type | info:eu-repo/semantics/bookPart | |
| dc.type | info:ar-repo/semantics/parte de libro | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.b254449e-537e-4586-9340-fb6d4c7f0348_T.pdf
- Tamaño:
- 6.88 MB
- Formato:
- Adobe Portable Document Format
- Descripción: